Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-26 @ 1:29 AM
Study NCT ID:
NCT04417894
Status:
COMPLETED
Last Update Posted:
2023-12-22
First Post:
2020-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-02
First Submit QC Date:
None
Study First Post Date:
2020-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-28
Results First Submit QC Date:
None
Results First Post Date:
2023-12-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL